Christopher Morabito - May 10, 2021 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Chief Medical Officer
Signature
/s/ Peter Thomson, as attorney-in-fact for Christopher Morabito
Stock symbol
FULC
Transactions as of
May 10, 2021
Transactions value $
$0
Form type
4
Date filed
5/12/2021, 04:30 PM
Next filing
Jun 29, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +163K $0.00 163K May 10, 2021 Common Stock 163K $10.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 10, 2021 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of May 10, 2021. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.